Stratford Pharmaceuticals, LLC Acquired by Eli Global


Eli Global LLC (“Eli”) announced that an affiliate has acquired 100 percent of Stratford Pharmaceuticals, LLC / DBA, Stratford Animal Health (“Stratford”) from its shareholders as of July 18, 2018.
The stock purchase of Stratford fits into Eli’s strategy to enter the global animal health industry. Stratford currently provides a wide arrangement of dermatology products to over 10,000 veterinary hospitals in the US and 8 other countries.  Stratford will continue to operate independently under the leadership of its Founder and CEO Brian Nugent out of its Oldsmar, FL corporate headquarters.
“Partnering with Eli Global was a natural fit as it allows Stratford to keep our corporate identity, provide stability and continuity for our amazing employees while continuing to provide excellent products and services to our large base of veterinary hospitals in the US and abroad. In addition, Eli Global’s resources include over 100 businesses with 7,500+ employees and over $20 Billion in proforma assets which will allow Stratford to continue its double-digit organic growth while at the same time being extremely aggressive in the pursuit of animal health acquisitions,” said Brian Nugent, President and CEO of Stratford.